share_log

Piper Sandler Maintains Overweight on Adaptive Biotechnologies, Lowers Price Target to $6

Benzinga ·  Nov 13, 2023 16:08

Piper Sandler analyst David Westenberg maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Overweight and lowers the price target from $13 to $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment